Multi-Refractory MM: Supporting the Patient Receiving a Novel T-Cell–Redirecting Bispecific Antibody
Multi-Refractory MM: Supporting the Patient Receiving a Novel T-Cell–Redirecting Bispecific Antibody - JHOP
Multi-Refractory MM: Supporting the Patient Receiving a Novel T-Cell–Redirecting Bispecific Antibody
Multi-Refractory MM: Supporting the Patient Receiving a Novel T-Cell-Redirecting Bispecific Antibody
•
Charise Gleason, MSN, NP-C, AOCNP; Patricia Mangan, MSN, CRNP
•
Season 1
•
Episode 1
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
AONN+ is pleased to present an exclusive podcast providing peer-to-peer nursing perspectives on the current role of immunotherapy in patients with advanced multiple myeloma (MM) and introducing a new class of agents: T-cell–redirecting bispecific antibodies (Tcr-bsAbs).